Humacyte receives FDA RMAT designation for Humacyl in vascular access for hemodialysis March 27, 2017 CenterWatch Staff
C4 Therapeutics, Calico partnered on targeted protein degradation therapeutics March 27, 2017 CenterWatch Staff
Woody Sherman joins Silicon Therapeutics as chief scientific officer March 27, 2017 CenterWatch Staff
FDA grants Breakthrough designation for Rituxan (Rituximab) in pemphigus vulgaris March 24, 2017 CenterWatch Staff